Can fatty liver disease cause elevated alanine aminotransferase (ALT)?
May 20, 2022
Source: Cainiu Health
Dr. Zhao Haiming
Introduction
Nonalcoholic fatty liver disease (NAFLD) can lead to elevated alanine aminotransferase (ALT) levels, typically 1–5 times the upper limit of normal—most commonly 2–3 times. Mild or simple fatty liver usually does not cause ALT elevation, and the majority of patients remain asymptomatic. Most cases are incidentally detected during routine physical examinations via hepatic color Doppler ultrasound, revealing hepatomegaly and steatotic (fatty) liver appearance.
During routine medical examinations, some individuals are found to have elevated alanine aminotransferase (ALT) levels. Many are unaware of what this elevation signifies or its underlying causes. Can nonalcoholic fatty liver disease (NAFLD) lead to elevated ALT?
Can fatty liver cause elevated ALT?
Fatty liver can indeed cause an increase in alanine aminotransferase (ALT), typically by 1.5-fold, and sometimes up to 2–3-fold above the normal reference range. Mild or simple fatty liver usually does not elevate ALT, and most patients remain asymptomatic. Fatty liver is often incidentally detected during routine abdominal ultrasound, revealing hepatomegaly and characteristic echogenic changes consistent with hepatic steatosis. In moderate-to-severe cases, histopathological features may include steatohepatitis or hepatic fibrosis. Besides elevated ALT, patients may also exhibit increased aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), blood glucose, and lipid levels. Common symptoms include fatigue, abdominal distension, and right upper quadrant discomfort or pain.
Management of fatty liver generally involves comprehensive, multidisciplinary strategies. For alcoholic fatty liver disease, abstinence from alcohol is essential. For nonalcoholic fatty liver disease (NAFLD), long-term integrated management is recommended—including balanced nutrition, smoking cessation, alcohol abstinence, regular physical activity, and weight control targeting a 7%–10% reduction in body weight—to normalize ALT levels. Currently, no specific pharmacotherapy is approved for NAFLD. However, reduced glutathione and bicyclol may be used to mitigate hepatic inflammation and lower ALT levels.
If your ALT level remains persistently and markedly elevated above the normal range, it is advisable to consult a healthcare provider for a thorough evaluation to determine the underlying cause. Potential etiologies include viral hepatitis, drug-induced liver injury, or other metabolic or inflammatory liver conditions. We hope this information proves helpful!
